Hippocalcin‐like 1 suppresses hepatocellular carcinoma progression by promoting p21Waf/Cip1 stabilization by activating the ERK1/2‐MAPK pathway
Yonglong Zhang(Hefei Cement Research Design Institute), Jie Liu(Gannan Medical University), Huilu Zhang(Fudan University), Haibo Yan(Shanghai Medical College of Fudan University), Jun Zhang(Shenzhen University Health Science Center), Yanfeng Liu(Shanghai Jiao Tong University), Qi Fan(Ministry of Education of the People's Republic of China), Ke Qiao(Shanghai Medical College of Fudan University), Jinlin Duan(Tongren Hospital), Guoquan Yan(Shanghai Medical College of Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine)
Cited by 58
Related Papers
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
|Nature Communications|2020|273
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity
|Journal of Biological Chemistry|2004|237
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183